| Mar'20 | Mar'19 | Sep'18 | Jun'18 | Sep'17 | Jun'17 | |
|---|---|---|---|---|---|---|
Net sales | ||||||
0 | 0 | - | - | - | - | |
Cost of sales | ||||||
0 | 0 | - | - | - | - | |
Revenue | ||||||
- | - | 0 | 0 | 0 | 0 | |
Cost of sales | ||||||
- | - | 0 | 0 | 0 | 0 | |
Gross profit | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Selling, general and administrative expenses | ||||||
0 | 0 | - | - | - | - | |
Selling expenses | ||||||
- | - | 0 | 0 | 0 | 0 | |
Research and development costs | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Other expenses, net | ||||||
0 | 0 | - | - | - | - | |
Restructuring expenses | ||||||
0 | 0 | - | - | - | - | |
Income from operations | ||||||
0 | 0 | - | - | - | - | |
Interest and other financial expense, net | ||||||
0 | 0 | - | - | - | - | |
Reclassification of actuarial losses from AOCI | ||||||
0 | 0 | - | - | - | - | |
Income from operations before income taxes and equity in earnings of affiliated companies | ||||||
0 | 0 | - | - | - | - | |
Income tax expense | ||||||
0 | 0 | - | - | - | - | |
Equity in earnings of affiliated companies, net of tax | ||||||
0 | 0 | - | - | - | - | |
Net income | ||||||
0 | 0 | - | - | - | - | |
Weighted-average shares outstanding (in thousands of shares): | ||||||
Basic (in shares) | ||||||
60,276 | 59,518 | - | - | - | - | |
Diluted (in shares) | ||||||
61,391 | 61,113 | - | - | - | - | |
Earnings per share: | ||||||
Basic (in USD per share) | ||||||
0.30 | 0.32 | - | - | - | - | |
Diluted (in USD per share) | ||||||
0.29 | 0.31 | - | - | - | - | |
Dividends per share (in USD per share) | ||||||
0.20 | 0.20 | - | - | - | - | |
General and administrative expenses | ||||||
- | - | 0 | 0 | 0 | 0 | |
Other operating income | ||||||
- | - | 0 | 0 | 0 | 0 | |
Other operating expenses | ||||||
- | - | 0 | 0 | 0 | 0 | |
Restructuring income | ||||||
- | - | 0 | 0 | 0 | 0 | |
Restructuring expenses | ||||||
- | - | 0 | 0 | 0 | 0 | |
Restructuring income/(expenses), net | ||||||
- | - | 0 | 0 | 0 | 0 | |
Earnings before taxes and finance income/costs (operating result (EBIT)) | ||||||
- | - | 0 | 0 | 0 | 0 | |
Finance income | ||||||
- | - | 0 | 0 | 0 | 0 | |
Finance costs | ||||||
- | - | 0 | 0 | 0 | 0 | |
Share of profit or loss of joint ventures | ||||||
- | - | 0 | 0 | 0 | 0 | |
Financial result | ||||||
- | - | 0 | 0 | 0 | 0 | |
Profit before income taxes | ||||||
- | - | 0 | 0 | 0 | 0 | |
Income taxes | ||||||
- | - | 0 | 0 | 0 | 0 | |
Profit for the period | ||||||
- | - | 0 | 0 | 0 | 0 | |
Earnings per share (USD per share), basic | ||||||
- | - | 0.40 | 0.88 | 0.26 | 0.31 | |
Weighted average number of ordinary shares, basic (in thousand of shares) | ||||||
- | - | 59,722 | 59,590 | 59,320 | 59,320 | |
Earnings per share (USD per share), diluted | ||||||
- | - | 0.40 | 0.87 | 0.25 | 0.30 | |
Weighted average number of ordinary shares, diluted (in thousand of shares) | ||||||
- | - | 60,867 | 60,743 | 60,460 | 60,460 | |